Theratechnologies Issues Preliminary Revenue Estimates for Fiscal Year 2019 and Revenue Guidance for Fiscal Year 2020

NEXT STORY
Achillion Shareholders Approve Agreement to be Acquired by Alexion
PREV STORY
Zenith Epigenetics Announces Clinical Advancement of ZEN-3694
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Curetis Provides Business Update for the First Nine Months of 2019

author_avatar
NASDAQ Market News

Tabula Rasa HealthCare to Present at the American Society for Clinical Pharmacology and Therapeutics Annual Meeting

MOORESTOWN, N.J., March 13, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) a ...

author_avatar
NASDAQ Market News

HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

author_avatar
NASDAQ Market News